May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Evaluation of the Pituitary-Adrenal Axis Function Following Intravitreal Triamcinolone Acetonide Injection
Author Affiliations & Notes
  • M. Amiran
    Ha'Emek Medical Center, Afula, Israel
    Ophthalmology,
  • Y. Lang
    Ha'Emek Medical Center, Afula, Israel
    Ophthalmology,
  • G. Sartani
    Ha'Emek Medical Center, Afula, Israel
    Ophthalmology,
  • I. Avraham
    Ha'Emek Medical Center, Afula, Israel
    Endocrine Institute,
  • R. Luboshitzky
    Ha'Emek Medical Center, Afula, Israel
    Endocrine Institute,
  • Footnotes
    Commercial Relationships  M. Amiran, None; Y. Lang, None; G. Sartani, None; I. Avraham, None; R. Luboshitzky, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5608. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Amiran, Y. Lang, G. Sartani, I. Avraham, R. Luboshitzky; Evaluation of the Pituitary-Adrenal Axis Function Following Intravitreal Triamcinolone Acetonide Injection. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5608.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the effects of a single 4mg/0.1ml intravitreal Triamcinolone Acetonide injection (IVTA) on the function of the pituitary-adrenal axis.

Methods: : Nineteen patients suffering from macular edema were treated with single IVTA injection. The basal cortisol level and the response to 1µg adrenocoticotropic hormone (ACTH) simulation were determined on the morning before treatment and at 1 day, 1-, 2-, and 4- weeks after IVTA injection. Results were compared with those obtained from a control-group of 19 healthy subjects.

Results: : Before treatment, all patients had basal (381 ± 110 nmol/L) and peak (676 ± 135 nmoles/liter) cortisol responses to ACTH at 30 minutes, which were similar to those in controls (395 ±130 nmoles/liter and 712 ±119 nmoles/liter, respectively). Blunted peak cortisol response (<585 nmoles/liter) at 30 minutes was observed in 7 out of 19 patients (36.8%) after 1 day, in 5 patients (26.3%) after 1 week, and in 4 patients (21%) 2 weeks after IVTA injection. In 2 of the 19 patients (10.5%) blunted cortisol was observed 4 weeks after IVTA.

Conclusions: : Single IVTA injection is associated with adrenocortical suppression presumably due systemic absorption of Triamcinolone.Maximal adrenocortical suppression may be observed during the first 2 weeks after IVTA.While recovery is expected in most patients within 4 weeks, some patients may exhibit adrenocortical suppression for over than 4 weeks after IVTA injection.

Keywords: corticosteroids • vitreous • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×